This compound is a deuterium-labeled derivative of abacavir, a nucleoside analog reverse transcriptase inhibitor. It is primarily used as a pharmaceutical intermediate or research compound in the development and manufacture of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1260619-56-4
Ganaplacide
pharmaceutical raw material
Telmisartan-13C,d3
pharmaceutical raw material
6-[4-hydroxy-7-methyl-3-oxo-6-(trideuterio(113C)methoxy)-1H-2-benzofuran-5-yl]-4-methylhex-4-enoic acid
pharmaceutical raw material
JTZ-951 hydrochloride
pharmaceutical raw material
Trans-Abacavir-d4 Hydrochloride
research compound
Abacavir
pharmaceutical raw material
Sulfuric acid--{(4S)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-1-en-1-yl}methanol (1/2)
pharmaceutical raw material
Abacavir sulfate
pharmaceutical raw material
[(1S,4R)-4-[2-amino-6-[(2,2,3,3-tetradeuteriocyclopropyl)amino]purin-9-yl]cyclopent-2-en-1-yl]methanol
MCGSCOLBFJQGHM-ZOTQTBSBSA-N
[2H]C1(C(C1([2H])[2H])NC2=C3C(=NC(=N2)N)N(C=N3)[C@@H]4C[C@@H](C=C4)CO)[2H]